Indication
Coronary Syndrome
2 clinical trials
3 products
Clinical trial
Characterisation of a Novel Regimen of Very Low-dose Aspirin Combined With Rivaroxaban in Patients With Chronic Coronary Syndromes: WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?Status: Completed, Estimated PCD: 2023-08-31
Product
AspirinProduct
RivaroxabanClinical trial
Optimal Target of Activated Clotting Time During Percutaneous Coronary Intervention and Outcomes: The Randomized OPTIMAL-ACT TrialStatus: Completed, Estimated PCD: 2021-10-25
Product
Unfractionated Heparin